S Windecker, S Stortecky, B Meier - Journal of the American College of …, 2014 - jacc.org
Paradoxical embolism is an important clinical entity among patients with venous thromboembolism in the presence of intracardiac or pulmonary shunts. The clinical …
S De Rosa, H Sievert, J Sabatino… - Annals of internal …, 2018 - acpjournals.org
Background: New evidence emerged recently regarding the percutaneous closure of patent foramen ovale (PFO) to prevent recurrent stroke in patients with cryptogenic stroke. Purpose …
J Li, J Liu, M Liu, S Zhang, Z Hao… - Cochrane Database …, 2015 - cochranelibrary.com
Background The optimal therapy for preventing recurrent stroke in people with cryptogenic stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
IB Riaz, MS Khan, H Riaz, RJ Goldberg - The American Journal of …, 2016 - Elsevier
The number of meta-analyses published annually has increased more than 20-fold between 1994 (n= 386) and 2014 (n= 8203). In examining how much of this increase in meta-analysis …
Background Patent foramen ovale (PFO) might be a risk factor for unexplained (“cryptogenic”) stroke or transient ischemic attack (TIA). We sought to determine the efficacy …
Objectives To describe medium‐to long‐term follow‐up of patients undergoing device closure of patent foramen ovale (PFO) for stroke or transient ischemic attack (TIA) …
V Schulze, Y Lin, A Karathanos, M Brockmeyer… - Clinical Research in …, 2018 - Springer
Background Previous randomized controlled trials (RCT) failed to demonstrate benefits of patent foramen ovale (PFO) closure (PFO-C) over medical therapy (MT) for secondary …
H Riaz, MS Khan, AL Schenone, AA Waheed… - American heart …, 2018 - Elsevier
Background Transcatheter closure of patent foramen ovale (PFO) after cryptogenic stroke has long been a contentious issue. Herein, we pool aggregate data examining safety and …